Despite the prominent role of VEGF-induced vascular permeability in pathogenesis, a greater collective molecular understanding of its regulatory mechanisms is necessary to therapeutically improve vascular barrier integrity to prevent subsequent edema and tissue damage in vascular diseases like myocardial infarction, ischemic stroke and acute lung injury. The gene discussed is VEGFA; the disease is acute lung injury.